T. Rowe Price Investment Management’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Buy |
6,484,787
+2,341,691
| +57% | +$5.78M | 0.01% | 529 |
|
|
2025
Q1 | $8.25M | Buy |
4,143,096
+165,268
| +4% | +$329K | 0.01% | 568 |
|
|
2024
Q4 | $11.6M | Buy |
3,977,828
+170,541
| +4% | +$498K | 0.01% | 546 |
|
|
2024
Q3 | $14.7M | Buy |
3,807,287
+81,560
| +2% | +$316K | 0.01% | 538 |
|
|
2024
Q2 | $19.2M | Buy |
3,725,727
+635,644
| +21% | +$3.27M | 0.01% | 504 |
|
|
2024
Q1 | $21.6M | Buy |
+3,090,083
| New | +$21.6M | 0.01% | 493 |
|